Additional risk genes in which we detected a VUS are also associated with lipid metabolism (e.g., FERMT2, BIN1, CR1) [56, 57], reinforcing the possibility that convergence of these genetic factors with APOE on this particular pathway bestows an increased AD risk. This evidence concerns the gene FERMT2 and Alzheimer disease.